Advertisement
| economic burden of diabetes: Managing Diabetes in Low Income Countries Ivica Smokovski, 2020-09-29 This book covers the complexity of diabetes and related complications and presents the socio-economic burden of the disease, taking into account the rising prevalence reaching pandemic proportions and the associated costs. Factors causing high diabetes prevalence and the influence of the pharmaceutical industry are evaluated and solutions for sustainable diabetes care with limited resources are provided, including national focus on providing cost-effective diabetes treatment, nutrition and physical activity, structured diabetes education and centralized National e-Health System. Moreover, elaboration of long-term efforts to curb the diabetes burden through prevention activities are presented in this book. Managing Diabetes in Low Income Countries represents an essential guide for diabetes care clinicians and researchers, medical students and clinicians in training, diabetes policy makers, regulatory authorities, international diabetes and patient organisations all of whom are involved in current clinical practice for diabetes management. |
| economic burden of diabetes: Assessing the Economic Costs of Unhealthy Diets and Low Physical Activity Centers of Disease Control, 2017-09-14 Unhealthy diets and low physical activity contribute to many chronic diseases and disability; they are responsible for some 2 in 5 deaths worldwide and for about 30% of the global disease burden. Yet surprisingly little is known about the economic costs that these risk factors cause, both for health care and society more widely. This study pulls together the evidence about the economic burden that can be linked to unhealthy diets and low physical activity and explores - How definitions vary and why this matters - The complexity of estimating the economic burden and - How we can arrive at a better way to estimate the costs of an unhealthy diet and low physical activity, using diabetes as an example The review finds that unhealthy diets and low physical activity predict higher health care expenditure, but estimates vary greatly. Existing studies underestimate the true economic burden because most only look at the costs to the health system. Indirect costs caused by lost productivity may be about twice as high as direct health care costs, together accounting for about 0.5% of national income. The study also tests the feasibility of using a disease-based approach to estimate the costs of unhealthy diets and low physical activity in Europe, projecting the total economic burden associated with these two risk factors as manifested in new type 2 diabetes cases at 883 million euros in 2020 for France, Germany, Italy, Spain and the United Kingdom alone. The true costs will be higher, as unhealthy diets and low physical activity are linked to many more diseases. The study's findings are a step towards a better understanding of the economic burden that can be associated with two key risk factors for ill health and they will help policymakers in setting priorities and to more effectively promoting healthy diets and physical activity. |
| economic burden of diabetes: Handbook of Global Health Ilona Kickbusch, Detlev Ganten, Matshidiso Moeti, 2021-05-11 Global health is a rapidly emerging discipline with a transformative potential for public policy and international development. Emphasizing transnational health issues, global health aims to improve health and achieve health equity for all people worldwide. Its multidisciplinary scope includes contributions from many disciplines within and beyond the health sciences, including clinical medicine, public health, social and behavioral sciences, environmental sciences, economics, public policy, law and ethics. This large reference offers up-to-date information and expertise across all aspects of global health and helps readers to achieve a truly multidisciplinary understanding of the topics, trends as well as the clinical, socioeconomic and environmental drivers impacting global health. As a fully comprehensive, state-of-the-art and continuously updated, living reference, the Handbook of Global Health is an important, dynamic resource to provide context for global health clinical care, organizational decision-making, and overall public policy on many levels. Health workers, physicians, economists, environmental and social scientists, trainees and medical students as well as professionals and practitioners will find this handbook of great value. |
| economic burden of diabetes: Obesity and Diabetes Joel Faintuch, Salomão Faintuch, 2020-12-14 Now in its second edition, this comprehensive handbook provides a state-of-the-art overview of recent advances in drug and non-drug therapies for obesity and diabetes. It also addresses major comorbidities, covering topics such as, cardiovascular diseases, renal and neuropsychiatric disorders, appetite control and micro RNAs. Special attention is also devoted to pediatric care, including the latest recommendations for therapy and prevention. Obesity and type 2 diabetes are among the top global health-care budget concerns worldwide and impact professional practice at all levels: in hospitals, clinics and physicians’ offices alike. They prominently feature in headlines, and virtually no family, community or country is exempt from their protean, deleterious consequences. Furthermore, given the multiple intersections in their pathways, they often go hand in hand. The good news is that scientific advances in all fields, including genomics, metabolomics, lipidomics and microbiomics, are increasing our understanding of these two disease areas. At the same time, artificial intelligence, machine learning, mobile health and advanced implantable and external devices are rendering prevention and management more available, safe and cost-effective. In addition, bariatric and metabolic surgery has evolved from a niche specialty to an officially endorsed option for several modalities of obesity and diabetes. This book presents the latest lifestyle, pharmacological, surgical and non-surgical treatment options, including endoscopic intervention and cell therapy. Objectively reviewing natural and artificial sweeteners and critically examining issues such as public health initiatives, government mandated taxes for unhealthy foods and environmental planning, no stone is left unturned in gathering the latest practical information. As such, the book will appeal to seasoned specialists, as well as students and healthcare professionals in training. |
| economic burden of diabetes: Diabetes Mellitus in Developing Countries and Underserved Communities Sam Dagogo-Jack, 2016-11-23 Adopting a truly global perspective and a practical approach to diabetes—including pathophysiology, genetics, regional peculiarities, management, prevention and best practices—this book is an excellent resource for clinicians and policy-makers working with patients in more austere settings. The global prevalence of diabetes is estimated to increase from 422 million in 2014 to 592 million in 2035. Sadly, low- and middle-economy countries are projected to experience the steepest increase, but even in developed economies, vulnerable demographic subgroups manifest disparities in diabetes prevalence, quality of care, and outcomes. This book extends coverage to those underserved and minority communities in the developed world. In a consistent chapter format, it discusses classification, pathophysiology, genomics, diagnosis, prevention and management of diabetes in economically challenged regions as well as underserved populations in affluent nations. Suggestions regarding future directions in the organization of diabetes care delivery, prevention and research priorities are also provided. The detailed identification of barriers to optimal care and the practical approach to the management and prevention of diabetes make Diabetes Mellitus in Developing Countries and Underserved Communities a valuable resource for clinicians, researchers and health policy leaders. |
| economic burden of diabetes: Management of Diabetic Retinopathy F. Bandello, M.A. Zarbin, R. Lattanzio, I. Zucchiatti, 2017-04-20 Recently developed diagnostic and therapeutic technologies such as OCT-angiography and small gauge vitrectomy have influenced the modern treatment of diabetic retinopathy. This volume provides a summary of the state-of-the-art evidence-based approach to managing complications that may occur with diabetic retinopathy. It offers the latest information on pathogenesis and diagnosis, and highly experienced clinicians review the results of relevant randomized clinical trials that serve as the basis of current therapy. The book provides not only a summary of data from randomized trials but also an analysis and interpretation by internationally renowned experts. Ophthalmology residents, fellows, and practicing clinicians will find this book to be a useful reference when seeking evidence-based treatment strategies for various complications of diabetic retinopathy. It is also for researchers identifying new avenues of drug developments and for insurance professionals and health care policy administrators who are establishing evidence-based therapy guidelines for therapeutic intervention. |
| economic burden of diabetes: A Cost-Benefit Analysis of Case Management Activities for Diabetes Felix J. Bradbury, 2010-06 The economic and human costs of diabetes in the U.S. population place an enormous burden on its healthcare system as well as on employers, diabetics, and their respective families. Many Medicare Advantage plans have responded to this burden by implementing diabetes case management programs (DCMPs) aimed at reducing inappropriate health services utilization, improving health outcomes, and containing costs. While the use of DCMPs is common to many health plans, the research regarding their effectiveness has been sparse or inconclusive. The purpose of this study was to help fill a critical gap in the research literature by evaluating the effect of a diabetes case management program known as CareContact on a Medicare population in Texas. The study population consisted of 2,972 confirmed diabetic members who were continuously enrolled in SelectCare of Texas, a Medicare Advantage plan, for the two-year period between January 1, 2005 and December 31, 2006. To be eligible for this study, diabetic members had to have a minimum of 6 months without exposure to CareContact and 6 months of exposure to CareContact after the initial exposure. Twelve separate cohorts, defined by date of initial program exposure, were evaluated using a one group interrupted time series design. Cross sectional time series analysis, which combines ordinary least square regression techniques and time series analyses, was used to evaluate program effectiveness. After controlling for confounders and the effects of time, the data indicated that membership in the DCMP was associated with increased costs and increased utilization over the two-year study period. The study points to the need for further research into the effectiveness of diabetes case management programs, especially for participants of Medicare Advantage health plans. |
| economic burden of diabetes: Disease Control Priorities, Third Edition (Volume 5) Dorairaj Prabhakaran, Shuchi Anand, Thomas A. Gaziano, Jean-Claude Mbanya, Rachel Nugent, 2017-11-17 Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs. |
| economic burden of diabetes: The Foot in Diabetes Andrew J. M. Boulton, Gerry Rayman, Dane K. Wukich, 2020-04-09 Fully revised and updated edition of this popular book, addressing all issues concerning the diabetic foot, one of the most prevalent problems in diabetes, with a strong emphasis on practical aspects of delivering care. |
| economic burden of diabetes: Disease and Mortality in Sub-Saharan Africa Dean T. Jamison, 2006-01-01 Current data and trends in morbidity and mortality for the sub-Saharan Region as presented in this new edition reflect the heavy toll that HIV/AIDS has had on health indicators, leading to either a stalling or reversal of the gains made, not just for communicable disorders, but for cancers, as well as mental and neurological disorders. |
| economic burden of diabetes: Diabetes in Old Age Alan J. Sinclair, Trisha Dunning, Leocadio Rodríguez Mañas, Medha Munshi, 2017-02-13 This new edition of the popular and market-leading Diabetes in Old Age features up-to-date and comprehensive information about the key aspects of managing older people with diabetes, predominantly type 2 diabetes. With a strong evidence-based focus throughout, the entire range of issues surrounding diabetes and its many complications are covered, each with a clear focus on how they relate directly to the older patient. Varying approaches to optimizing diabetes care in the community, primary care and secondary care health care arenas are presented, and the importance of comprehensive functional assessment is emphasized. Coverage of areas unique to an ageing population of older people with diabetes such as falls management, frailty and sarcopenia, and cognitive dysfunction form a key cornerstone of the book. In every chapter, best practice points and key learning outcomes are provided, as well as published evidence bases for each major conclusion. Diabetes in Old Age, 4th edition is essential reading for diabetologists and endocrinologists, diabetes specialist nurses, primary care physicians, general physicians and geriatricians, podiatrists and dieticians with an interest in diabetes, as well as all health professionals engaged in the delivery of diabetes care to older people. |
| economic burden of diabetes: International Textbook of Diabetes Mellitus R. A. DeFronzo, E. Ferrannini, Paul Zimmet, George Alberti, 2015-03-11 The International Textbook of Diabetes Mellitus has been a successful, well-respected medical textbook for almost 20 years, over 3 editions. Encyclopaedic and international in scope, the textbook covers all aspects of diabetes ensuring a truly multidisciplinary and global approach. Sections covered include epidemiology, diagnosis, pathogenesis, management and complications of diabetes and public health issues worldwide. It incorporates a vast amount of new data regarding the scientific understanding and clinical management of this disease, with each new edition always reflecting the substantial advances in the field. Whereas other diabetes textbooks are primarily clinical with less focus on the basic science behind diabetes, ITDM's primary philosophy has always been to comprehensively cover the basic science of metabolism, linking this closely to the pathophysiology and clinical aspects of the disease. Edited by four world-famous diabetes specialists, the book is divided into 13 sections, each section edited by a section editor of major international prominence. As well as covering all aspects of diabetes, from epidemiology and pathophysiology to the management of the condition and the complications that arise, this fourth edition also includes two new sections on NAFLD, NASH and non-traditional associations with diabetes, and clinical trial evidence in diabetes. This fourth edition of an internationally recognised textbook will once again provide all those involved in diabetes research and development, as well as diabetes specialists with the most comprehensive scientific reference book on diabetes available. |
| economic burden of diabetes: Global Report on Diabetes Gojka Roglic, 2016 On the occasion of World Health Day 2016, WHO issues a call for action on diabetes, drawing attention to the need to step up prevention and treatment of the disease. The first WHO Global report on diabetes demonstrates that the number of adults living with diabetes has almost quadrupled since 1980 to 422 million adults. This dramatic rise is largely due to the rise in type 2 diabetes and factors driving it include overweight and obesity. In 2012 alone diabetes caused 1.5 million deaths. Its complications can lead to heart attack, stroke, blindness, kidney failure and lower limb amputation. The new report calls upon governments to ensure that people are able to make healthy choices and that health systems are able to diagnose, treat and care for people with diabetes. It encourages us all as individuals to eat healthily, be physically active, and avoid excessive weight gain.--Publisher's description. |
| economic burden of diabetes: National Nursing Home Survey , 1999 |
| economic burden of diabetes: The Diabetes Textbook Joel Rodriguez-Saldana, 2019-06-27 Diabetes has become a worldwide health problem, the global estimated prevalence approaches ten percent and the burden of this disease in terms of morbidity and mortality is unprecedented. The advances acquired through the knowledge of the mechanisms of the disease and the variety of therapeutic approaches contrast with the inability of private and public health systems in underdeveloped and even developed countries to achieve the goals of treatment. This paradox has been described in many sources: the surge of scientific advances contrast with an unprecedented amount of human suffering. Thus, a patient centered and an evidence based approach with the capacity to produce measurable clinical and economic outcomes is required. The purpose of this textbook is multiple: to offer a comprehensive resource covering all aspects of outpatient management; to address diabetes as a health problem from an epidemiological, economic and clinical perspective; to discuss the role of social determinants of health on the worldwide increase in diabetes; to highlight the challenges and obstacles in providing adequate care; and to outline a multidisciplinary approach to management in which medical visits retain their importance as part of a team comprising the patient, his or her family and a multidisciplinary group of health professionals who are able to move beyond the traditional approach of diabetes as a disease and greatly improve outcomes. |
| economic burden of diabetes: Priorities in Health , 2006-01-01 This companion guide to Disease Control Priorities in Developing Countries, 2nd edition speeds the diffusion of life-saving knowledge by distilling the contents of the larger volume into an easily read format. Policy makers, practitioners, academics, and other interested readers will get an overview of the messages and analysis in Disease Control Priorities in Developing Countries, 2nd edition; be alerted to the scope of major diseases; learn strategies to improve policies and choices to implement cost-effective interventions; and locate chapters of immediate interest. |
| economic burden of diabetes: Essentials of Pharmacoeconomics Karen Rascati, 2013-11-14 This new text is designed for a student or practitioner who is unfamiliar with pharmacoeconomics. It provides a straightforward explanation of the essential pharmacoeconomics topics outlined by The Accreditation Council for Pharmacy Education (ACPE). It defines terminology used in research and covers the application of economic-based evaluation methods for pharmaceutical products and services. Users will find examples of how pharmacoeconomic evaluations relate to decisions that affect patient care and health-related quality of life--Provided by publisher. |
| economic burden of diabetes: The Epidemiology of Diabetes Mellitus Jean Marie Ekoé, Marian Rewers, Rhys Williams, Paul Zimmet, 2008-09-15 The first edition of this book gained recognition as the definitive textbook of diabetes epidemiology. The second edition builds on this success, gathering recent information on international trends and data for diabetes mellitus. In particular, the book highlights the dramatic rise of Type 2 diabetes in children, adolescents and the elderly throughout the world. One new section features prevention and screening of both Type1 and Type 2 diabetes. Other new chapters cover the epidemiology of obesity and the impact of nutrition, and review available guidelines for better worldwide glycemic control. Future challenges, including the effects of antipsychotic treatment and HIV infection and therapy on diabetes, are also addressed. All chapters have been completely revised and updated, covering: definitions, classification and risk factors for diabetes new evidence for screening and prevention of Type 1 and Type 2 diabetes epidemiology of complications and associated risk factors economic aspects: the direct and indirect costs of diabetes. The Epidemiology of Diabetes Mellitus fills the need for a current compendium of diabetes epidemiology in the tradition of the first monumental text of the late Kelly West. It is essential reading for general practitioners, diabetologists, clinical endocrinologists, cardiologists, epidemiologists, nurses, dieticians, and other diabetes care providers, as well as health care decision makers. |
| economic burden of diabetes: Type 2 Diabetes in Children and Adolescents Arlan L. Rosenbloom, Janet H. Silverstein, 2003 As a consequence of the obesity epidemic, the prevalence of type 2 diabetes in children and adolescents is increasing. For medical trend watchers and health care professionals alike, this groundbreaking book covers epidemiology of type 2 diabetes in youth; pathophysiology of type 2 in youth; case-finding criteria; early recognition of risk factors; prevention of obesity in this population; and more. |
| economic burden of diabetes: Oxford Textbook of Global Public Health Roger Detels, Martin Gulliford, Quarraisha Abdool Karim, Chorh Chuan Tan, 2017 Sixth edition of the hugely successful, internationally recognised textbook on global public health and epidemiology, with 3 volumes comprehensively covering the scope, methods, and practice of the discipline |
| economic burden of diabetes: Managing Diabetes and Hyperglycemia in the Hospital Setting Boris Draznin, 2016-05-20 As the number of patients with diabetes increases annually, it is not surprising that the number of patients with diabetes who are admitted to the hospital also increases. Once in the hospital, patients with diabetes or hyperglycemia may be admitted to the Intensive Care Unit, require urgent or elective surgery, enteral or parenteral nutrition, intravenous insulin infusion, or therapies that significantly impact glycemic control (e.g., steroids). Because many clinical outcomes are influenced by the degree of glycemic control, knowledge of the best practices in inpatient diabetes management is extremely important. The field of inpatient management of diabetes and hyperglycemia has grown substantially in the last several years. This body of knowledge is summarized in this book, so it can reach the audience of hospitalists, endocrinologists, nurses and other team members who take care of hospitalized patients with diabetes and hyperglycemia. |
| economic burden of diabetes: Disease Control Priorities, Third Edition (Volume 4) Vikram Patel, Dan Chisholm, Tarun Dua, Ramanan Laxminarayan, Mari'a Lena Medina-Mora, Theo Vos, 2016-03-10 Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders. |
| economic burden of diabetes: OECD Health Policy Studies Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care OECD, 2015-06-17 This report examines how countries perform in their ability to prevent, manage and treat cardiovascular disease (CVD) and diabetes. |
| economic burden of diabetes: Diabetes in the Middle East Mohamed Abu-Farha, Jehad Ahmed Abubaker, Jaakko Tuomilehto, 2021-03-29 |
| economic burden of diabetes: Disease Control Priorities, Third Edition (Volume 1) Haile T. Debas, Peter Donkor, Atul Gawande, Dean T. Jamison, Margaret E. Kruk, Charles N. Mock, 2015-03-23 Essential Surgery is part of a nine volume series for Disease Control Priorities which focuses on health interventions intended to reduce morbidity and mortality. The Essential Surgery volume focuses on four key aspects including global financial responsibility, emergency procedures, essential services organization and cost analysis. |
| economic burden of diabetes: Psychosocial Care for People with Diabetes Deborah Young-Hyman, Mark Peyrot, 2012-12-25 Psychosocial Care for People with Diabetes describes the major psychosocial issues which impact living with and self-management of diabetes and its related diseases, and provides treatment recommendations based on proven interventions and expert opinion. The book is comprehensive and provides the practitioner with guidelines to access and prescribe treatment for psychosocial problems commonly associated with living with diabetes. |
| economic burden of diabetes: Sleep Disorders and Sleep Deprivation Institute of Medicine, Board on Health Sciences Policy, Committee on Sleep Medicine and Research, 2006-10-13 Clinical practice related to sleep problems and sleep disorders has been expanding rapidly in the last few years, but scientific research is not keeping pace. Sleep apnea, insomnia, and restless legs syndrome are three examples of very common disorders for which we have little biological information. This new book cuts across a variety of medical disciplines such as neurology, pulmonology, pediatrics, internal medicine, psychiatry, psychology, otolaryngology, and nursing, as well as other medical practices with an interest in the management of sleep pathology. This area of research is not limited to very young and old patientsâ€sleep disorders reach across all ages and ethnicities. Sleep Disorders and Sleep Deprivation presents a structured analysis that explores the following: Improving awareness among the general public and health care professionals. Increasing investment in interdisciplinary somnology and sleep medicine research training and mentoring activities. Validating and developing new and existing technologies for diagnosis and treatment. This book will be of interest to those looking to learn more about the enormous public health burden of sleep disorders and sleep deprivation and the strikingly limited capacity of the health care enterprise to identify and treat the majority of individuals suffering from sleep problems. |
| economic burden of diabetes: Diabetes in America , 1995 |
| economic burden of diabetes: Government-Sponsored Health Insurance in India Gerard La Forgia, Somil Nagpal, 2012-09-14 This book presents the first comprehensive review of all major government-supported health insurance schemes in India and their potential for contributing to the achievement of universal coverage in India are discussed. |
| economic burden of diabetes: Relieving Pain in America Institute of Medicine, Board on Health Sciences Policy, Committee on Advancing Pain Research, Care, and Education, 2011-10-26 Chronic pain costs the nation up to $635 billion each year in medical treatment and lost productivity. The 2010 Patient Protection and Affordable Care Act required the Department of Health and Human Services (HHS) to enlist the Institute of Medicine (IOM) in examining pain as a public health problem. In this report, the IOM offers a blueprint for action in transforming prevention, care, education, and research, with the goal of providing relief for people with pain in America. To reach the vast multitude of people with various types of pain, the nation must adopt a population-level prevention and management strategy. The IOM recommends that HHS develop a comprehensive plan with specific goals, actions, and timeframes. Better data are needed to help shape efforts, especially on the groups of people currently underdiagnosed and undertreated, and the IOM encourages federal and state agencies and private organizations to accelerate the collection of data on pain incidence, prevalence, and treatments. Because pain varies from patient to patient, healthcare providers should increasingly aim at tailoring pain care to each person's experience, and self-management of pain should be promoted. In addition, because there are major gaps in knowledge about pain across health care and society alike, the IOM recommends that federal agencies and other stakeholders redesign education programs to bridge these gaps. Pain is a major driver for visits to physicians, a major reason for taking medications, a major cause of disability, and a key factor in quality of life and productivity. Given the burden of pain in human lives, dollars, and social consequences, relieving pain should be a national priority. |
| economic burden of diabetes: Reducing the Impact of Dementia in America National Academies of Sciences Engineering and Medicine, Division of Behavioral and Social Sciences and Education, Board on Behavioral Cognitive and Sensory Sciences, Committee on the Decadal Survey of Behavioral and Social Science Research on Alzheimer's Disease and Alzheimer's Disease-Related Dementias, 2022-04-26 As the largest generation in U.S. history - the population born in the two decades immediately following World War II - enters the age of risk for cognitive impairment, growing numbers of people will experience dementia (including Alzheimer's disease and related dementias). By one estimate, nearly 14 million people in the United States will be living with dementia by 2060. Like other hardships, the experience of living with dementia can bring unexpected moments of intimacy, growth, and compassion, but these diseases also affect people's capacity to work and carry out other activities and alter their relationships with loved ones, friends, and coworkers. Those who live with and care for individuals experiencing these diseases face challenges that include physical and emotional stress, difficult changes and losses in their relationships with life partners, loss of income, and interrupted connections to other activities and friends. From a societal perspective, these diseases place substantial demands on communities and on the institutions and government entities that support people living with dementia and their families, including the health care system, the providers of direct care, and others. Nevertheless, research in the social and behavioral sciences points to possibilities for preventing or slowing the development of dementia and for substantially reducing its social and economic impacts. At the request of the National Institute on Aging of the U.S. Department of Health and Human Services, Reducing the Impact of Dementia in America assesses the contributions of research in the social and behavioral sciences and identifies a research agenda for the coming decade. This report offers a blueprint for the next decade of behavioral and social science research to reduce the negative impact of dementia for America's diverse population. Reducing the Impact of Dementia in America calls for research that addresses the causes and solutions for disparities in both developing dementia and receiving adequate treatment and support. It calls for research that sets goals meaningful not just for scientists but for people living with dementia and those who support them as well. By 2030, an estimated 8.5 million Americans will have Alzheimer's disease and many more will have other forms of dementia. Through identifying priorities social and behavioral science research and recommending ways in which they can be pursued in a coordinated fashion, Reducing the Impact of Dementia in America will help produce research that improves the lives of all those affected by dementia. |
| economic burden of diabetes: The World Health Report 1997 World Health Organization, 1997 Increases in life expectancy, combined with changes in lifestyles are leading to global epidemics of cancer and other chronic diseases. These may cause an increase in human suffering and disability. This report focuses on chronic non-communicable diseases such as cancer and heart disease, diabetes and rheumatic conditions and mental and neurological disorders. It examines the causes of these diseases and highlights the main risk factors in their development. In each area, priorities for international action in terms of prevention, treatment, cure and rehabilitation are suggested. This report focuses on major chronic non-communicable diseases such as cancer and heart disease, diabetes and rheumatic conditions, and mental and neurological disorders. It shows that the bonuses of an increasing life span are in danger of being outweighed by the burden of chronic diseases which kill over 24 million people a year, nearly half of all deaths worldwide. |
| economic burden of diabetes: Pharmacoeconomics Renee J. G. Arnold, 2016-04-19 The pharmaceutical industry is almost boundless in its ability to supply new drug therapies, but how does one decide which are the best medicines to use within restricted budgets? With particular emphasis on modeling, methodologies, data sources, and application to real-world dilemmas, Pharmacoeconomics: From Theory to Practice provides an introduc |
| economic burden of diabetes: Changing Numbers, Changing Needs National Research Council, Division of Behavioral and Social Sciences and Education, Commission on Behavioral and Social Sciences and Education, Committee on Population, 1996-10-11 The reported population of American Indians and Alaska Natives has grown rapidly over the past 20 years. These changes raise questions for the Indian Health Service and other agencies responsible for serving the American Indian population. How big is the population? What are its health care and insurance needs? This volume presents an up-to-date summary of what is known about the demography of American Indian and Alaska Native populationâ€their age and geographic distributions, household structure, employment, and disability and disease patterns. This information is critical for health care planners who must determine the eligible population for Indian health services and the costs of providing them. The volume will also be of interest to researchers and policymakers concerned about the future characteristics and needs of the American Indian population. |
| economic burden of diabetes: Diabetes Action Now , 2004 |
| economic burden of diabetes: Death to Diabetes: The 6 Stages of Type 2 Diabetes Control & Reversal DeWayne McCulley, 2005 How to control and reverse Type 2 diabetes in 6 stages, from an ex-diabetic/engineer with a glucose level over 1300 and 4 insulin shots/day. Using 5 super foods and wellness protocols supported by 250+ clinicals, was able to wean off insulin in 4 months, with an average glucose level 88.5, A1C 4.4%.www.DeathToDiabetes.com |
| economic burden of diabetes: Eating and Activity Guidelines for New Zealand Adults New Zealand. Ministry of Health, Louise McIntyre, Anna Jackson, Harriette Carr, Mary-Ann Carter, Sally Mackay, Sarah Gerritsen, 2020 These Guidelines provide the current evidence-based recommendations on healthy eating and physical activity for New Zealand adults, including pregnant and breastfeeding women. ... focus on the detail practitioners need at a glance: that is, what people need to eat or do, a summary of the rationale - 'why' - and a little on how to put the recommendations into practice--Page iv. |
| economic burden of diabetes: Health Economics Gisela Kobelt, 2013 |
| economic burden of diabetes: Economic Aspects of Diabetes DIANE Publishing Company, 1993-12 Contains over 200 abstracts of articles, reports, materials, and programs selected to provide professionals with a base of information on the economic aspects of diabetes care, including third-party reimbursement for outpatient education. 4 indices. |
| economic burden of diabetes: Diabetes Cost Journey Azhar ul Haque Sario, 2024-09-23 Embark on a Journey Through the Labyrinth of Diabetes Costs Diabetes Cost Journey isn't just a book—it's a compass guiding you through the intricate financial maze that diabetes creates. It's a tale of two costs: the direct hit to your wallet from medications and hospital stays, and the silent drain of lost work and missed opportunities. We'll witness the cost-effectiveness of various treatments, realizing that smart choices can lighten the load. We'll feel the weight of socioeconomic factors, understanding how income and education shape the financial burden. From the role of health insurance to groundbreaking solutions, we'll traverse the globe, comparing costs across countries. We'll delve into the emotional toll, recognizing that financial stress leaves scars on the mind. Empowerment through knowledge is key. We'll witness how informed patients, armed with understanding, can navigate this challenging terrain. We'll hear the voices of advocates and policymakers, striving for a world where diabetes care is affordable for all. Families grapple with the financial strain, employers offer support, and we'll glimpse the future where technology might revolutionize diabetes management. Ethical dilemmas arise, forcing us to confront questions of equity and access. Real-life stories offer raw, unfiltered insights. The power of nutrition and the link between mental health and diabetes unfold. We'll address the unique challenges of aging with diabetes. This is a call to action—a plea for collaboration and innovation. It's a reminder that diabetes isn't just a medical condition, it's a financial journey. But together, we can navigate this path, ensuring that cost doesn't stand in the way of a fulfilling life. |
News Release - American Diabetes Association
The Economic Report, which is published every five years, found that the total annual cost of diabetes in 2022 is $412.9 billion, including $306.6 billion in direct medical costs and $106.3 …
Diabetes and Its Economic Repercussions - iomcworld.com
Diabetes is a pervasive chronic disease with significant economic repercussions globally. This article examines the economic impact of diabetes, focusing on direct and indirect costs as well …
A systematic review of the economic burden of diabetes …
Type 2 diabetes greatly costs healthcare institutions, reducing economic productivity and eficiency. This cost of illness (COI) analysis examines the direct and indirect costs of treating …
Economic Costs Attributable to Diabetes in Each U.S. State
The estimated economic cost of diabetes, including direct medical costs and indirect productivity losses, in the U.S. was $245 billion in 2012, was $327 billion in 2017 (3,4), and has been …
The global economic burden of diabetes in adults aged 20â …
We estimate the full global economic burden of diabetes in adults aged 20–79 years in 2015, using a unified framework across all countries. Our objective was to highlight patterns of …
Diabetes State Burden Toolkit Technical Report - Chronic …
The diabetes burden toolkit consists of three sections: (1) diabetes health burden, (2) diabetes economic burden, and (3) diabetes mortality and health-related quality of life. In the following …
Chapt.30 - Economic Impact of Diabetes - National Institute …
Americans with diabetes have two to five times higher per capita total medical expenditures and per capita out-of-pocket expenses than people without diabetes. These expenses and their …
The Burden of Diabetes by State - American Diabetes …
Diabetes and prediabetes cost an estimated $5.4 billion in Alabama each year. The serious include heart disease, stroke, amputation, end-stage kidney disease, blindness – and death. …
Economic Costs of Diabetes in - American Diabetes Association
We combine the demographics of the U.S. population in 2022 with diabetes preva-lence, from national survey data, epidemiological data, health care cost data, and economic data, into a …
Facing the Diabetes Cost Crisis: A Guide for Employers
The economic burden of diabetes in the U.S. is substantial, with the total estimated cost of diagnosed diabetes reaching approximately $412.9 billion in 2022. This figure includes both …
Economic Costs of Diabetes in the U.S. in 2017 - Kansas State …
economic cost to the Medicare program. The estimates in this article highlight the substantial financial burden that diabetes imposes on society, in addition to intan-gible costs from pain …
The Economic Costs of Type 2 Diabetes: A Global Systematic …
There has been a widely documented and recognized increase in diabetes prevalence, not only in high-income countries (HICs) but also in low- and middle-income countries (LMICs), over …
Economic burden of diabetes care: The economic burden on …
The rising pattern of the prevalence of Diabetes Mellitus and the early mortality due to diabetes increased the financial costs over families and governments (3) with noticeable press on the …
Economic Costs of Diabetes in the U.S. in 2012 - Archive.org
In this updated cost of di-abetes study, we estimate the total na-tional economic burden of diagnosed diabetes in 2012 re ecting continued fl growth in prevalence of diabetes and its …
The Staggering Costs of Diabetes - American Diabetes …
diabetes than non-Hispanic white people. The total cost of diagnosed diabetes and prediabetes in the U.S. is $412.9 billion. Spending on insulin has tripled between 2012 and 2022. People with …
Projected rapid growth in diabetes disease burden and …
the economic burden of diabetes is essential for devel-oping better societal support for individuals living with diabetes. Estimation of the economic burden of diabetes relies on accurate data on …
The Economic Burden of Diabetes Mellitus among Clients …
Objective: This study tended to measure the magnitude of economic burden borne by diabetes mellitus to individual’s patient and their families attending health facilities in Hawassa city, …
The Burden of Diabetes in California - American Diabetes …
Total direct medical expenses for diagnosed diabetes in California were estimated at $27 billion in 2017. In addition, another $12.5 billion was spent on indirect costs from lost productivity due to …
The Economic Burden of Diabetes Mellitus in the WHO …
economic burden of diabetes equals direct cost plus indirect cost. Direct cost equals diagnostic cost plus cost of medicines (insulin and oral drugs) plus cost of devices for injecting insulin …
The Burden of Diabetes in New York - American Diabetes …
Diabetes is expensive: People with diabetes have medical expenses approximately 2.3 times higher than those who do not have diabetes. Total direct medical expenses for diagnosed …
News Release - American Diabetes Association
The Economic Report, which is published every five years, found that the total annual cost of diabetes in 2022 is $412.9 billion, including $306.6 billion in direct medical costs and $106.3 …
Diabetes and Its Economic Repercussions - iomcworld.com
Diabetes is a pervasive chronic disease with significant economic repercussions globally. This article examines the economic impact of diabetes, focusing on direct and indirect costs as well …
A systematic review of the economic burden of diabetes …
Type 2 diabetes greatly costs healthcare institutions, reducing economic productivity and eficiency. This cost of illness (COI) analysis examines the direct and indirect costs of treating …
Economic Costs Attributable to Diabetes in Each U.S. State
The estimated economic cost of diabetes, including direct medical costs and indirect productivity losses, in the U.S. was $245 billion in 2012, was $327 billion in 2017 (3,4), and has been …
The global economic burden of diabetes in adults aged 20â …
We estimate the full global economic burden of diabetes in adults aged 20–79 years in 2015, using a unified framework across all countries. Our objective was to highlight patterns of …
Diabetes State Burden Toolkit Technical Report - Chronic …
The diabetes burden toolkit consists of three sections: (1) diabetes health burden, (2) diabetes economic burden, and (3) diabetes mortality and health-related quality of life. In the following …
Chapt.30 - Economic Impact of Diabetes - National Institute …
Americans with diabetes have two to five times higher per capita total medical expenditures and per capita out-of-pocket expenses than people without diabetes. These expenses and their …
The Burden of Diabetes by State - American Diabetes …
Diabetes and prediabetes cost an estimated $5.4 billion in Alabama each year. The serious include heart disease, stroke, amputation, end-stage kidney disease, blindness – and death. …
Economic Costs of Diabetes in - American Diabetes …
We combine the demographics of the U.S. population in 2022 with diabetes preva-lence, from national survey data, epidemiological data, health care cost data, and economic data, into a …
Facing the Diabetes Cost Crisis: A Guide for Employers
The economic burden of diabetes in the U.S. is substantial, with the total estimated cost of diagnosed diabetes reaching approximately $412.9 billion in 2022. This figure includes both …
Economic Costs of Diabetes in the U.S. in 2017 - Kansas …
economic cost to the Medicare program. The estimates in this article highlight the substantial financial burden that diabetes imposes on society, in addition to intan-gible costs from pain …
The Economic Costs of Type 2 Diabetes: A Global …
There has been a widely documented and recognized increase in diabetes prevalence, not only in high-income countries (HICs) but also in low- and middle-income countries (LMICs), over …
Economic burden of diabetes care: The economic burden …
The rising pattern of the prevalence of Diabetes Mellitus and the early mortality due to diabetes increased the financial costs over families and governments (3) with noticeable press on the …
Economic Costs of Diabetes in the U.S. in 2012 - Archive.org
In this updated cost of di-abetes study, we estimate the total na-tional economic burden of diagnosed diabetes in 2012 re ecting continued fl growth in prevalence of diabetes and its …
The Staggering Costs of Diabetes - American Diabetes …
diabetes than non-Hispanic white people. The total cost of diagnosed diabetes and prediabetes in the U.S. is $412.9 billion. Spending on insulin has tripled between 2012 and 2022. People with …
Projected rapid growth in diabetes disease burden and …
the economic burden of diabetes is essential for devel-oping better societal support for individuals living with diabetes. Estimation of the economic burden of diabetes relies on accurate data on …
The Economic Burden of Diabetes Mellitus among Clients …
Objective: This study tended to measure the magnitude of economic burden borne by diabetes mellitus to individual’s patient and their families attending health facilities in Hawassa city, …
The Burden of Diabetes in California - American Diabetes …
Total direct medical expenses for diagnosed diabetes in California were estimated at $27 billion in 2017. In addition, another $12.5 billion was spent on indirect costs from lost productivity due to …
The Economic Burden of Diabetes Mellitus in the WHO …
economic burden of diabetes equals direct cost plus indirect cost. Direct cost equals diagnostic cost plus cost of medicines (insulin and oral drugs) plus cost of devices for injecting insulin …
The Burden of Diabetes in New York - American Diabetes …
Diabetes is expensive: People with diabetes have medical expenses approximately 2.3 times higher than those who do not have diabetes. Total direct medical expenses for diagnosed …
